Apritant 150mg Injection
Marketer
MSN Laboratories
Salt Composition
Fosaprepitant (150mg)
Overview Apritant 150mg Injection
Aprepitant 150mg injection, a prescription medication, prevents chemotherapy-induced nausea and vomiting. Administered by a healthcare professional, this injection should be taken consistently as prescribed. Discontinuing treatment prematurely requires prior consultation with your physician. Missed doses should be taken as soon as recalled, completing the entire treatment regimen even with symptom improvement. Regular liver function tests may be recommended by your doctor. Potential side effects include fatigue, headache, decreased appetite, constipation, and hiccups. Drowsiness and dizziness are also possible; avoid driving or activities demanding concentration until the medication's effects are understood.
Uses of Apritant 150mg Injection
Chemotherapy-induced emesis
Major Benefits of Apritant 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Apritant 150mg Injection:
- Headache
- Hiccup
- Indigestion
- Fatigue
- Decreased appetite
- Constipation
How to use Apritant 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Apritant 150mg Injection works:
Neupaka (apritant 150mg injection) is a drug used to prevent nausea and vomiting. Its mechanism involves inhibiting neurokinin, a brain chemical that triggers these side effects, often experienced with cancer therapies like chemotherapy.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Apritant 150mg Injection is inadvisable.
PregnancySAFE IF PRESCRIBED
The injectable form of apitrant (150mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals have revealed minimal or no harmful effects on fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCONSULT YOUR DOCTOR
Using the injectable form of apitrant (150mg) while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administration of a 150mg injection of aprepitant can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, the 150mg Apritant injection presents a safe treatment option; no dosage modification is necessary.
LiverCAUTION
For patients with severe liver impairment, cautious administration of the 150mg Apritant Injection is advised. Dosage modification of the 150mg Apritant Injection may be necessary; physician consultation is recommended. Dosage changes are not typically required for those with moderate to severe hepatic dysfunction.
What if you forget to take Apritant 150mg Injection :
Should you forget a dose of the 150mg Apritant injection, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Apritant 150mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylmorpholine-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Substances Blocking NK1 Receptors |
3,018 People bought this recently